Search Results - "Wedi, B."

Refine Results
  1. 1
  2. 2

    EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria by Zuberbier, T, Asero, R, Bindslev-Jensen, C, Walter Canonica, G, Church, M.K, Giménez-Arnau, A, Grattan, C.E.H, Kapp, A, Merk, H.F, Rogala, B, Saini, S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Schünemann, H, Staubach, P, Vena, G.A, Wedi, B, Maurer, M

    Published in Allergy (Copenhagen) (01-10-2009)
    “…This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK,…”
    Get full text
    Journal Article
  3. 3

    Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany by Weller, K., Maurer, M., Bauer, A., Wedi, B., Wagner, N., Schliemann, S., Kramps, T., Baeumer, D., Multmeier, J., Hillmann, E., Staubach, P.

    “…Background Comprehensive data on the epidemiology and comorbidities of chronic urticaria (CU) in Germany are either limited, or not contemporary. Objectives To…”
    Get full text
    Journal Article
  4. 4

    National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE‐II by Larenas‐Linnemann, D. E. S., Antolín‐Amérigo, D., Parisi, C., Nakonechna, A., Luna‐Pech, J. A., Wedi, B., Davila, I., Gómez, M., Levin, M., Ortega Martell, J. A., Klimek, L., Rosario, N., Muraro, A. M., Agache, I., Bousquet, J., Sheikh, A., Pfaar, O.

    Published in Allergy (Copenhagen) (01-03-2018)
    “…Background Since 1988, numerous allergen immunotherapy guidelines (AIT‐GLs) have been developed by national and international organizations to guide physicians…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Lanadelumab to treat hereditary angioedema by Wedi, B

    Published in Drugs of today (Barcelona, Spain : 1998) (01-07-2019)
    “…Lanadelumab is a human monoclonal antibody against plasma kallikrein indicated for prevention of attacks of hereditary angioedema (HAE). HAE is caused by…”
    Get full text
    Journal Article
  8. 8

    Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects by Raap, U., Deneka, N., Bruder, M., Kapp, A., Wedi, B.

    Published in Clinical and experimental allergy (01-09-2008)
    “…Summary Background Recent studies suggest that neurotrophins have a pivotal role in neuroimmune interactions. Indeed, in contrast to nonatopic subjects (NA),…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Circulating levels of brain‐derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis by Raap, U., Werfel, T., Goltz, C., Deneka, N., Langer, K., Bruder, M., Kapp, A., Schmid‐Ott, G., Wedi, B.

    Published in Allergy (Copenhagen) (01-12-2006)
    “…Background:  Recent studies have shed light on the complex regulation of genetic, environmental, immunologic and pharmacologic factors, which contribute to the…”
    Get full text
    Journal Article
  11. 11

    Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria by Durda, J, Wedi, B, Martin, V, Breuer, K

    Published in Allergologie select (04-08-2017)
    “… H antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines…”
    Get full text
    Journal Article
  12. 12

    Brain-derived neurotrophic factor is increased in serum and skin levels of patients with chronic spontaneous urticaria by Rössing, K., Novak, N., Mommert, S., Pfab, F., Gehring, M., Wedi, B., Kapp, A., Raap, U.

    Published in Clinical and experimental allergy (01-10-2011)
    “…Summary Background Chronic spontaneous urticaria is triggered by many direct and indirect aggravating factors including autoreactive/autoimmune mechanisms,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression—Inhibitory effects of anti-inflammatory drugs by Wedi, Bettina, Novacovic, Vera, Koerner, Michael, Kapp, Alexander

    Published in Journal of allergy and clinical immunology (01-03-2000)
    “…Background: A role of potential histamine-releasing autoantibodies against the high-affinity IgE receptor on the surface of basophils and mast cells is…”
    Get full text
    Journal Article
  15. 15

    Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine by Kapp, A, Wedi, B

    Published in Journal of drugs in dermatology (01-11-2004)
    “…Chronic urticaria (CU) involves release of histamine from mast cells and/or basophils, which in turn promotes the classic inflammatory cascade. The resultant…”
    Get more information
    Journal Article
  16. 16

    Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis by Wedi, Bettina, Raap, Ulrike, Lewrick, Heitje, Kapp, Alexander

    Published in Journal of allergy and clinical immunology (01-10-1997)
    “…The present studies were undertaken to characterize the potential role of eosinophil programmed cell death (PCD) in atopic diseases. Peripheral blood…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20